Bristol-Myers, AstraZeneca Agree To End Drug Patent Fight - Law360

Bristol-Myers, AstraZeneca Agree To End Drug Patent Fight – Law360

Source Node: 2797250
By Lauren Berg (July 31, 2023, 11:32 PM EDT) — A Delaware federal judge on Monday dismissed Bristol-Myers Squibb Co.’s litigation accusing AstraZeneca of infringing cancer treatment patents to create a rival immunotherapy drug, after the pharmaceutical giants reached an agreement….

Time Stamp:

More from Law 360